article thumbnail

The Society of Thoracic Surgeons Launches New Valve Surgery Risk Calculators

DAIC

Analysis of 13,587 patients undergoing isolated tricuspid valve surgery from 2017 to 2023 revealed a 5.5% SAVR after TAVR Surgical aortic valve replacement after prior TAVR is the fastest-growing cardiac surgery procedure in the U.S. overall predicted risk of mortality for isolated repair and a 5.7% and 4.1%, respectively.

TAVR 111
article thumbnail

Midterm outcomes of transcatheter aortic valve replacement in patients with active cancer

Open Heart

Objectives The clinical outcomes of transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis (AS) and concomitant active cancer remain insufficiently explored. This study aimed to assess the midterm outcomes of TAVR in patients diagnosed with AS and active cancer. vs 74.7%, p=0.50).

article thumbnail

STS Announces Late-breaker Research to Be Presented at the 2024 Annual Meeting

DAIC

Cardiac Surgery after Transcatheter Aortic Valve Replacement: Trends and Outcomes The researchers set out to document trends and outcomes in cardiac surgery following transcatheter aortic valve replacement (TAVR), a topic gaining importance as reports of subsequent cardiac operations and early TAVR explantations increase.

Research 111
article thumbnail

Impact of elevated left ventricular filling pressure on long-term outcomes after transcatheter aortic valve replacement

Open Heart

However, the impact of elevated FP as detected by pretranscatheter aortic valve replacement (TAVR) echocardiogram on long-term outcomes after TAVR remains unclear. Objective To understand the impact of elevated FP in patients with severe AS who undergo TAVR. Patients with elevated FP had a mean age of 81.2±8.6

article thumbnail

Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients with Atrial Fibrillation

Circulation

Background: Atrial fibrillation (AF) is common in patients undergoing transcatheter aortic valve replacement (TAVR) and is associated with increased risk of bleeding and stroke. Patients were randomized 1:1 to TAVR+LAAO or TAVR+medical therapy. For the composite primary endpoint, TAVR+.LAAO and HAS-BLED score was 3.0.

article thumbnail

Published Research

Society of Thoracic Surgeons - Research

Laurie Shroyer Single- Versus Multicenter Surgeons' Risk-Adjusted Coronary Artery Bypass Graft Procedural Outcomes The Annals of Thoracic Surgery May 2018 Thomas Schwann Operative Outcomes of Multiple-Arterial Versus Single-Arterial Coronary Bypass Grafting The Annals of Thoracic Surgery April 2018 Alexander Brescia Determinants of Variation in Pneumonia (..)

article thumbnail

Published Research

Society of Thoracic Surgeons - Research

Laurie Shroyer 1 Single- Versus Multicenter Surgeons' Risk-Adjusted Coronary Artery Bypass Graft Procedural Outcomes The Annals of Thoracic Surgery May 2018 Thomas Schwann Operative Outcomes of Multiple-Arterial Versus Single-Arterial Coronary Bypass Grafting The Annals of Thoracic Surgery April 2018 Alexander Brescia Determinants of Variation in Pneumonia (..)